Table 2.
Excluded outliers
| HemosIL AcuStar | BioPlex | EliA | QUANTA Lite | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aβ2GPI IgM | aCL IgM | aβ2GPI IgG | aCL IgG | aβ2GPI IgM | aCL IgM | aβ2GPI IgG | aCL IgG | aβ2GPI IgM | aCL IgM | aβ2GPI IgG | aCL IgG | aβ2GPI IgM | aCL IgM | aβ2GPI IgG | aCL IgG |
| U/mL | U/mL | U/mL | U/mL | U/mL | MPL‐U/mL | U/mL | GPL‐U/mL | U/mL | MPL‐U/mL | U/mL | GPL‐U/mL | SMU | MPL | SGU | GPL |
| 7.6 | 26.0 | 8.2 | 4.8 | 10.0 | 12.3 | <1.4 | 1.9 | 2.5 | 6.3 | 1.4 | 2.6 | 7.0 | 8.1 | 3.9 | 6.8 |
| 8.4 | 26.1 | 8.2 | 5.4 | 10.6 | 12.5 | 1.7 | 2.3 | 2.5 | 8.1 | 1.4 | 2.7 | 7.5 | 8.1 | 3.9 | 6.9 |
| 11.8 | 26.1 | 8.3 | 5.9 | 12.0 | 12.5 | 1.9 | 2.4 | 2.6 | 8.3 | 1.4 | 3.2 | 7.6 | 8.7 | 3.9 | 6.9 |
| 12.2 | 32.5 | 10.3 | 7.4 | 12.5 | 12.8 | 2.2 | 2.6 | 3.3 | 8.8 | 1.5 | 3.9 | 7.9 | 9.4 | 4.0 | 7.0 |
| 14.1 | 33.5 | 11.0 | 7.9 | 13.6 | 19.9 | 2.3 | 2.7 | 3.5 | 9.6 | 1.8 | 6.5 | 8.0 | 11.7 | 4.1 | 7.1 |
| 15.0 | 45.1 | 11.5 | 7.9 | 18.0 | 21.2 | 2.4 | 4.3 | 3.8 | 10.0 | 1.9 | 10.0 | 10.1 | 12.1 | 4.2 | 7.2 |
| 16.6 | 53.5 | 27.0 | 8.4 | 20.7 | 33.7 | 2.9 | 5.3 | 4.6 | 12.0 | 2.1 | 11.0 | 10.7 | 12.8 | 4.3 | 8.5 |
| 16.9 | 63.5 | 31.3 | 21.1 | 27.8 | 43.9 | 3.2 | 6.4 | 4.9 | 17.0 | 7.5 | 16.0 | 20.8 | 15.3 | 5.8 | 10.2 |
| 20.0 | 64.2 | 49.0 | 24.5 | 29.1 | 46.8 | 26.3 | 26.6 | 11.0 | 18.0 | 25.0 | 37.0 | 24.0 | 21.9 | 6.6 | 11.7 |
| 34.0 | 247.8 | 159.4 | 47.3 | 75.0 | 63.2 | 149.5 | ≥ 160.0 | 24.0 | 23.0 | 39.0 | 51.0 | 24.8 | 27.0 | 19.0 | 72.8 |
The 10 highest concentrations are shown for each antibody. Outliers as identified by the Reed outlier test are underlined. Outliers as identified by the Tietjen‐Moore outlier test are indicated in bold.
aβ2GPI, anti‐β2 glycoprotein I antibodies; aCL, anticardiolipin antibodies; GPL, IgG phospholipid units; MPL, IgM phospholipid units; SGU, standard IgG units; SMU, standard IgM units.